[Evaluation of immunotherapy in breast cancer (stage III-IV) and in cancer of the corpus uteri (stage I-III)].
A new clinically-tested procedure of adjuvant immunotherapy carried out in conjunction with anticoagulant treatment is discussed. Application of said method has significantly improved the short-term and end results of treatment of inoperable cases of breast cancer, stage III-IV, receiving chemotherapy and patients with cancer of corpus uteri, stage I-III, receiving combined therapy plus radiation.
Mkrtchian
L N
LN
The V.A. Fanarjian Center for Oncology Research, Ministry of Health of the Republic of Armenia, Yerevan.
Movsesian
M A
MA
Adamian
R T
RT
Barsegian
A M
AM
D000925:Anticoagulants / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007167:Immunotherapy; D009367:Neoplasm Staging; D016896:Treatment Outcome; D014594:Uterine Neoplasms / Q000473:pathology / Q000628:therapy*
D000925:Anticoagulants
Otsenka rezul'tatov immunokhimioterapii bol'nykh rakom molochnoĭ zhelezy (III-IV stadiia) i tela matki (I-III stadii).